Annual Shareholders Equity
-$440.18 M
-$534.01 M-569.14%
December 31, 2023
Summary
- As of February 8, 2025, RNAC annual stockholders equity is -$440.18 million, with the most recent change of -$534.01 million (-569.14%) on December 31, 2023.
- During the last 3 years, RNAC annual shareholders equity has fallen by -$422.18 million (-2344.65%).
- RNAC annual shareholders equity is now -569.14% below its all-time high of $93.83 million, reached on December 31, 2022.
Performance
RNAC Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$752.00 K
+$102.21 M+100.74%
September 1, 2024
Summary
- As of February 8, 2025, RNAC quarterly stockholders equity is $752.00 thousand, with the most recent change of +$102.21 million (+100.74%) on September 1, 2024.
- Over the past year, RNAC quarterly shareholders equity has increased by +$117.55 million (+100.64%).
- RNAC quarterly shareholders equity is now -99.20% below its all-time high of $93.83 million, reached on December 1, 2022.
Performance
RNAC Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
RNAC Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -569.1% | +100.6% |
| 3 y3 years | -2344.7% | -99.2% |
| 5 y5 years | -8024.5% | -99.2% |
RNAC Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -569.1% | at low | -99.2% | +100.2% |
| 5 y | 5-year | -569.1% | at low | -99.2% | +100.2% |
| alltime | all time | -569.1% | at low | -99.2% | +100.2% |
Cartesian Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $752.00 K(-100.7%) |
| Jun 2024 | - | -$101.46 M(-13.1%) |
| Mar 2024 | - | -$116.80 M(-73.5%) |
| Dec 2023 | -$440.18 M(-569.1%) | -$440.18 M(-829.6%) |
| Sep 2023 | - | $60.33 M(-7.8%) |
| Jun 2023 | - | $65.45 M(-12.2%) |
| Mar 2023 | - | $74.58 M(-20.5%) |
| Dec 2022 | $93.83 M(+316.6%) | - |
| Dec 2022 | - | $93.83 M(+10.5%) |
| Sep 2022 | - | $84.91 M(-5.2%) |
| Jun 2022 | - | $89.61 M(+60.7%) |
| Mar 2022 | - | $55.76 M(+147.6%) |
| Dec 2021 | $22.52 M(-225.1%) | $22.52 M(-220.2%) |
| Sep 2021 | - | -$18.73 M(+343.7%) |
| Jun 2021 | - | -$4.22 M(-78.4%) |
| Mar 2021 | - | -$19.57 M(+8.7%) |
| Dec 2020 | -$18.01 M | -$18.01 M(+143.9%) |
| Sep 2020 | - | -$7.38 M(-43.4%) |
| Jun 2020 | - | -$13.05 M(+48.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | -$8.76 M(-204.4%) |
| Dec 2019 | $8.40 M(-255.0%) | $8.40 M(-270.8%) |
| Sep 2019 | - | -$4.92 M(-8876.8%) |
| Jun 2019 | - | $56.00 K(-99.6%) |
| Mar 2019 | - | $14.82 M(-373.5%) |
| Dec 2018 | -$5.42 M(-110.5%) | -$5.42 M(-154.2%) |
| Sep 2018 | - | $10.00 M(-58.8%) |
| Jun 2018 | - | $24.26 M(-41.7%) |
| Mar 2018 | - | $41.58 M(-19.7%) |
| Dec 2017 | $51.81 M(-5.7%) | $51.81 M(-20.4%) |
| Sep 2017 | - | $65.08 M(-16.8%) |
| Jun 2017 | - | $78.18 M(+90.3%) |
| Mar 2017 | - | $41.09 M(-25.2%) |
| Dec 2016 | $54.96 M(-147.2%) | $54.96 M(-16.0%) |
| Sep 2016 | - | $65.44 M(-4.8%) |
| Jun 2016 | - | $68.78 M(+379.5%) |
| Mar 2016 | - | $14.34 M(-112.3%) |
| Dec 2015 | -$116.49 M(+32.7%) | -$116.49 M |
| Dec 2014 | -$87.75 M | - |
FAQ
- What is Cartesian Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Cartesian Therapeutics?
- What is Cartesian Therapeutics annual shareholders equity year-on-year change?
- What is Cartesian Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Cartesian Therapeutics?
- What is Cartesian Therapeutics quarterly shareholders equity year-on-year change?
What is Cartesian Therapeutics annual stockholders equity?
The current annual shareholders equity of RNAC is -$440.18 M
What is the all time high annual shareholders equity for Cartesian Therapeutics?
Cartesian Therapeutics all-time high annual stockholders equity is $93.83 M
What is Cartesian Therapeutics annual shareholders equity year-on-year change?
Over the past year, RNAC annual stockholders equity has changed by -$534.01 M (-569.14%)
What is Cartesian Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of RNAC is $752.00 K
What is the all time high quarterly shareholders equity for Cartesian Therapeutics?
Cartesian Therapeutics all-time high quarterly stockholders equity is $93.83 M
What is Cartesian Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, RNAC quarterly stockholders equity has changed by +$117.55 M (+100.64%)